Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Fatigue 4Vomiting 3Nausea 3Hematopoietic and Lymphatic System Neoplasm 3Breast Neoplasms 3Prostatic Neoplasms 2Pancreatic Neoplasms 2Pain 2Neoplasms 2Lung Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms 2Syndrome 1Supportive Care 1Stomach Neoplasms 1Rectal Neoplasms 1Radiation Injuries 1Ovarian Neoplasms 1Neoplasms, Second Primary 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Glioblastoma 1Gastrointestinal Neoplasms 1Gastro-enteropancreatic neuroendocrine tumor 1Dyspnea 1Disease 1Depression 1Cough 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Temozolomide 264Radiotherapy 119Bevacizumab 105Magnetic Resonance Spectroscopy 59Radiation 47pembrolizumab 30Irinotecan 28Surgical Procedures, Operative 23Lomustine 21Specimen Handling 19Nivolumab 19Radiosurgery 18Carmustine 18Aminolevulinic Acid 16Erlotinib Hydrochloride 15Drug Therapy 15Blood Specimen Collection 14Radiotherapy, Intensity-Modulated 13O(6)-benzylguanine 13Chemotherapy, Adjuvant 13Carboplatin 13Filgrastim 11Cyclophosphamide 11sargramostim 10poly ICLC 10atezolizumab 10Thalidomide 10Etoposide 10Ipilimumab 9Everolimus 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Glioblastoma × Acupressure × Clear all
NCT03185780 2018-11-28

Complementary/Integrative Medicine for Brain Cancer Patients

The Chaim Sheba Medical Center

Phase NA Withdrawn
CNS

Glioblastoma, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡